15250-m-cuypers

126 Chapter 6 REFERENCES 1. Chen RC, Basak R, Meyer A, et al. Association between choice of radical prostatectomy, external beam radiotherapy, brachytherapy, or active surveillance and patient-reported quality of life among men with localized prostate cancer. JAMA. 2017;317(11):1141-50. 2. Holmes-Rovner M, Montgomery JS, Rovner DR, Scherer LD, Whitfield J, Kahn VC, et al. Informed Decision Making: Assessment of the Quality of Physician Communication about Prostate Cancer Diagnosis and Treatment. Medical Decision Making. 2015;35(8):999-1009. 3. Pieterse AH, Henselmans I, de Haes HCJM, Koning CCE, Geijsen ED, Smets EMA. Shared decision making: Prostate cancer patients’ appraisal of treatment alternatives and oncologists’ eliciting and responding behavior, an explorative study. Patient Education and Counseling. 2011;85(3):e251-e9. 4. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JWW, Comber H, et al. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. European Journal of Cancer. 2013;49(6):1374-403. 5. Carter HB, Albertsen PC, Barry MJ, Etzioni R, Freedland SJ, Greene KL, et al. Early Detection of Prostate Cancer: AUA Guideline. The Journal of Urology. 2013;190(2):419-26. 6. Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, van der Kwast T, et al. EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent— Update 2013. European Urology. 2014;65(1):124-37. 7. Cooperberg MR, Carroll PR, Klotz L. Active Surveillance for Prostate Cancer: Progress and Promise. Journal of Clinical Oncology. 2011;29(27):3669-76. 8. DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, et al. Cancer treatment and survivorship statistics, 2014. CA: A Cancer Journal for Clinicians. 2014;64(4):252-71. 9. Resnick MJ, Koyama T, Fan K-H, Albertsen PC, Goodman M, Hamilton AS, et al. Long-Term Functional Outcomes after Treatment for Localized Prostate Cancer. New England Journal of Medicine. 2013;368(5):436-45. 10. van Tol-Geerdink JJ, Leer JWH, van Oort IM, van Lin EJNT, Weijerman PC, Vergunst H, et al. Quality of life after prostate cancer treatments in patients comparable at baseline. Br J Cancer. 2013;108(9):1784-9. 11. Bellardita L, Valdagni R, van den Bergh R, Randsdorp H, Repetto C, Venderbos LDF, et al. How Does Active Surveillance for Prostate Cancer Affect Quality of Life? A Systematic Review. European Urology. 2015;67(4):637-45. 12. van StamM-A, van der Poel HG, van der Voort van Zyp JRN, Tillier CN, Horenblas S, Aaronson NK, et al. The accuracy of patients’perceptions of the risks associated with localised prostate cancer treatments. BJU International.2018; 121(3): 405-414. 13. Christie DRH, Sharpley CF, Bitsika V. Why do patients regret their prostate cancer treatment? A systematic review of regret after treatment for localized prostate cancer. Psycho-Oncology. 2015;24(9):1002-11.